CFG920
CFG920 is an orally active CYP17A1 inhibitor that suppresses androgen synthesis in the testes and adrenal glands. It is used in research for prostate cancer, investigating androgen signaling pathways in both in vitro cellular assays and in vivo xenograft models.
Product Specifications
CAS Number
1260006-20-9
Field of Research
Metabolism Research
Smiles
O=C1N (CCN1C=2C=C (Cl) N=CC2) C=3C (C) =CC=NC3
Molecular Formula
C14H13ClN4O
Molecular Weight
288.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
27673061 1.0 µg DNA
LRRC43 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
TMEM149-9303M 50 µg
Recombinant Mouse TMEM149 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details bsm-62656R-BF488-TR 20 µL
SF3A3 Recombinant Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details 